Trial intelligence / Profile preview

PESCA: Polypill vs Usual Care on Carotid Intima-media Thickness in High Risk CVD

NCT01326676Phase 3Withdrawn

Sponsor
Imperial College London
Start
Feb 2011
Primary completion
Jul 2012
Modality
Small Molecules, Drug Delivery Systems
Countries
3
01

Overview

A Phase 3 trial of Red Heart Pill in cardiovascular disease (CVD), sponsored by Imperial College London. Planned start Feb 2011; status: withdrawn.

02

Drugs

Red Heart Pill
03

Conditions

cardiovascular disease (CVD)

Beyond the preview

Go deeper on NCT01326676.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01326676.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call